Ligustrazine inhibits inflammatory response of human endometrial stromal cells through the STAT3/IGF2BP1/RELA axis
AbstractContext Endometriosis (EMs) is a gynecological disorder. Ligustrazine has been reported to exert an anti-inflammatory effect on EMs. However, the underlying mechanisms are not completely understood.Objective To investigate the effects of ligustrazine on the progression of EMs and the underly...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Pharmaceutical Biology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/13880209.2023.2195883 |
_version_ | 1797234835354288128 |
---|---|
author | Ying Feng Han Dong Liyan Zheng |
author_facet | Ying Feng Han Dong Liyan Zheng |
author_sort | Ying Feng |
collection | DOAJ |
description | AbstractContext Endometriosis (EMs) is a gynecological disorder. Ligustrazine has been reported to exert an anti-inflammatory effect on EMs. However, the underlying mechanisms are not completely understood.Objective To investigate the effects of ligustrazine on the progression of EMs and the underlying regulatory mechanisms.Materials and methods Human endometrial stromal cells (HESCs) were isolated from patients with EMs or control subjects. HESCs were treated with 25, 50, 100, or 200 μM ligustrazine for 1, 3, 6, or 12 h. Western blot and enzyme-linked immunosorbent assays were performed to determine the levels of proteins and inflammatory cytokines, respectively. The binding between STAT3 and insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) was assessed by chromatin immunoprecipitation and dual-luciferase reporter assays. The relationship between IGF2BP1 and RELA was assessed by RNA immunoprecipitation and RNA pull-down assay.Results Phosphorylated STAT3, IGF2BP1, RELA, TNF-α, IL-6, and IL-1β were upregulated in EMs tissues compared with control tissues (by 1.79-, 2.55-, 1.58-, 3.01-, 2.55-, and 3.34-fold, respectively). Ligustrazine inhibited the expression of p-STAT3, IGF2BP1, RELA, IL-6, TNF-α, and IL-1β. Overexpression of STAT3 promoted RELA-mediated inflammatory responses, while ligustrazine (100 µM) notably reversed this phenomenon. Ligustrazine also alleviated RELA-induced inflammation via downregulating IGF2BP1. STAT3 bound to the promoter of IGF2BP1, and IGF2BP1 bound to the RELA mRNA.Discussion and conclusion Ligustrazine inhibited inflammation in EMs via regulating the STAT3/IGF2BP1/RELA axis. These findings propose a new agent against EMs and support the development of ligustrazine-based treatment strategies for EMs. |
first_indexed | 2024-03-09T00:09:14Z |
format | Article |
id | doaj.art-6fb2b2cd94d84dd8bc5744fe99e2a727 |
institution | Directory Open Access Journal |
issn | 1388-0209 1744-5116 |
language | English |
last_indexed | 2024-04-24T16:38:23Z |
publishDate | 2023-12-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | Pharmaceutical Biology |
spelling | doaj.art-6fb2b2cd94d84dd8bc5744fe99e2a7272024-03-29T11:10:26ZengTaylor & Francis GroupPharmaceutical Biology1388-02091744-51162023-12-0161166667310.1080/13880209.2023.2195883Ligustrazine inhibits inflammatory response of human endometrial stromal cells through the STAT3/IGF2BP1/RELA axisYing Feng0Han Dong1Liyan Zheng2The Second Affiliated Hospital of Nanchang University, Nanchang, P.R. ChinaDepartment of Obstetrics and Gynecology, Gynecology Women and Children’s Hospital of Jinzhou, Jinzhou, P.R. ChinaDepartment of Obstetrics and Gynecology, ShangRao Guangxin District Traditional Chinese Medicine Hospital, Shangrao, P.R. ChinaAbstractContext Endometriosis (EMs) is a gynecological disorder. Ligustrazine has been reported to exert an anti-inflammatory effect on EMs. However, the underlying mechanisms are not completely understood.Objective To investigate the effects of ligustrazine on the progression of EMs and the underlying regulatory mechanisms.Materials and methods Human endometrial stromal cells (HESCs) were isolated from patients with EMs or control subjects. HESCs were treated with 25, 50, 100, or 200 μM ligustrazine for 1, 3, 6, or 12 h. Western blot and enzyme-linked immunosorbent assays were performed to determine the levels of proteins and inflammatory cytokines, respectively. The binding between STAT3 and insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) was assessed by chromatin immunoprecipitation and dual-luciferase reporter assays. The relationship between IGF2BP1 and RELA was assessed by RNA immunoprecipitation and RNA pull-down assay.Results Phosphorylated STAT3, IGF2BP1, RELA, TNF-α, IL-6, and IL-1β were upregulated in EMs tissues compared with control tissues (by 1.79-, 2.55-, 1.58-, 3.01-, 2.55-, and 3.34-fold, respectively). Ligustrazine inhibited the expression of p-STAT3, IGF2BP1, RELA, IL-6, TNF-α, and IL-1β. Overexpression of STAT3 promoted RELA-mediated inflammatory responses, while ligustrazine (100 µM) notably reversed this phenomenon. Ligustrazine also alleviated RELA-induced inflammation via downregulating IGF2BP1. STAT3 bound to the promoter of IGF2BP1, and IGF2BP1 bound to the RELA mRNA.Discussion and conclusion Ligustrazine inhibited inflammation in EMs via regulating the STAT3/IGF2BP1/RELA axis. These findings propose a new agent against EMs and support the development of ligustrazine-based treatment strategies for EMs.https://www.tandfonline.com/doi/10.1080/13880209.2023.2195883Endometriosisinflammationtumor necrosis factor-αinterleukin-1βinterleukin-6 |
spellingShingle | Ying Feng Han Dong Liyan Zheng Ligustrazine inhibits inflammatory response of human endometrial stromal cells through the STAT3/IGF2BP1/RELA axis Pharmaceutical Biology Endometriosis inflammation tumor necrosis factor-α interleukin-1β interleukin-6 |
title | Ligustrazine inhibits inflammatory response of human endometrial stromal cells through the STAT3/IGF2BP1/RELA axis |
title_full | Ligustrazine inhibits inflammatory response of human endometrial stromal cells through the STAT3/IGF2BP1/RELA axis |
title_fullStr | Ligustrazine inhibits inflammatory response of human endometrial stromal cells through the STAT3/IGF2BP1/RELA axis |
title_full_unstemmed | Ligustrazine inhibits inflammatory response of human endometrial stromal cells through the STAT3/IGF2BP1/RELA axis |
title_short | Ligustrazine inhibits inflammatory response of human endometrial stromal cells through the STAT3/IGF2BP1/RELA axis |
title_sort | ligustrazine inhibits inflammatory response of human endometrial stromal cells through the stat3 igf2bp1 rela axis |
topic | Endometriosis inflammation tumor necrosis factor-α interleukin-1β interleukin-6 |
url | https://www.tandfonline.com/doi/10.1080/13880209.2023.2195883 |
work_keys_str_mv | AT yingfeng ligustrazineinhibitsinflammatoryresponseofhumanendometrialstromalcellsthroughthestat3igf2bp1relaaxis AT handong ligustrazineinhibitsinflammatoryresponseofhumanendometrialstromalcellsthroughthestat3igf2bp1relaaxis AT liyanzheng ligustrazineinhibitsinflammatoryresponseofhumanendometrialstromalcellsthroughthestat3igf2bp1relaaxis |